Strategies to Target Glucose Metabolism in Tumor Microenvironment on Cancer by Flavonoids

Gang Wang1,2, Jun-Jie Wang1,2, Rui Guan2

  • 1a Department of Pharmaceutics , Jiangsu University , Shanghai , China.

Nutrition and Cancer
|March 22, 2017
PubMed

Insights

Flavonoids regulate cancer cell growth and glucose metabolism within the tumor microenvironment (TME). Identifying flavonoids targeting cancer

Area of Science:

  • Oncology
  • Biochemistry
  • Metabolomics

Background:

  • Cancer progression is linked to imbalances in glucose metabolism within the tumor microenvironment (TME).
  • Flavonoids possess antioxidant and anticarcinogenic properties, with emerging roles in cancer glucose metabolism.
  • Understanding flavonoid interactions with cancer cell metabolism is crucial for developing novel therapeutic strategies.

Purpose of the Study:

  • To review the role of flavonoids in modulating glucose metabolism and cancer cell growth in the TME.
  • To explore how flavonoids impact cancer hallmarks like proliferation, mobility, chemoresistance, and thermal sensitivity.
  • To identify potential therapeutic targets for cancer treatment based on flavonoid activity.

Main Methods:

  • Literature review focusing on studies investigating flavonoids, glucose metabolism, and cancer.
  • Analysis of research on flavonoid mechanisms in regulating cancer cell proliferation, migration, and drug resistance.
  • Examination of flavonoids' influence on thermal sensitivity in cancer cells within the TME.

Main Results:

  • Flavonoids can modulate key aspects of cancer cell metabolism and growth in the TME.
  • Specific flavonoids demonstrate potential in targeting alternative glucose metabolism pathways.
  • Flavonoids influence cancer cell proliferation, mobility, chemoresistance, and thermal sensitivity.

Conclusions:

  • Flavonoids represent promising agents for targeting cancer's metabolic vulnerabilities.
  • Targeting glucose metabolism pathways with flavonoids offers a potential avenue for effective cancer therapy.
  • Further research into natural and synthesized flavonoids can uncover new therapeutic strategies and targets for cancer treatment.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
56
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K